Loading...
Header Logo
Keywords
Last Name
Institution

SHI-MING TU

TitleProfessor
InstitutionMD Anderson
DepartmentGenitourinary Medical Oncology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lafata JE, Shin Y, Flocke SA, Hawley ST, Jones RM, Resnicow K, Schreiber M, Shires DA, Tu SP. Randomised trial to evaluate the effectiveness and impact of offering postvisit decision support and assistance in obtaining physician-recommended colorectal cancer screening: the e-assist: Colon Health study-a protocol study. BMJ Open. 2019 Jan 07; 9(1):e023986. PMID: 30617102.
      View in: PubMed
    2. Mishra V, Tu SP, Heim J, Masters H, Hall L, Clark RR, Dow AW. Predicting the Future: Using Simulation Modeling to Forecast Patient Flow on General Medicine Units. J Hosp Med. 2019 01 08; 14(1):9-15. PMID: 30534642.
      View in: PubMed
    3. Kegler MC, Liang S, Weiner BJ, Tu SP, Friedman DB, Glenn BA, Herrmann AK, Risendal B, Fernandez ME. Measuring Constructs of the Consolidated Framework for Implementation Research in the Context of Increasing Colorectal Cancer Screening in Federally Qualified Health Center. Health Serv Res. 2018 12; 53(6):4178-4203. PMID: 30260471.
      View in: PubMed
    4. Walker TJ, Risendal B, Kegler MC, Friedman DB, Weiner BJ, Williams RS, Tu SP, Fernandez ME. Assessing Levels and Correlates of Implementation of Evidence-Based Approaches for Colorectal Cancer Screening: A Cross-Sectional Study With Federally Qualified Health Centers. Health Educ Behav. 2018 12; 45(6):1008-1015. PMID: 29991294.
      View in: PubMed
    5. Gu J, Maxwell AE, Ma GX, Qian X, Tan Y, Hsieh HC, Tu SP, Wang JH. Evaluating the Training of Chinese-Speaking Community Health Workers to Implement a Small-Group Intervention Promoting Mammography. J Cancer Educ. 2018 Apr 14. PMID: 29654506.
      View in: PubMed
    6. Fernandez ME, Walker TJ, Weiner BJ, Calo WA, Liang S, Risendal B, Friedman DB, Tu SP, Williams RS, Jacobs S, Herrmann AK, Kegler MC. Developing measures to assess constructs from the Inner Setting domain of the Consolidated Framework for Implementation Research. Implement Sci. 2018 03 27; 13(1):52. PMID: 29587804.
      View in: PubMed
    7. Huynh C, Bowles D, Yen MS, Phillips A, Waller R, Hall L, Tu SP. Change implementation: the association of adaptive reserve and burnout among inpatient medicine physicians and nurses. J Interprof Care. 2018 Sep; 32(5):549-555. PMID: 29558229.
      View in: PubMed
    8. Huei-Yu Wang J, Ma GX, Liang W, Tan Y, Makambi KH, Dong R, Vernon SW, Tu SP, Mandelblatt JS. Physician Intervention and Chinese Americans' Colorectal Cancer Screening. Am J Health Behav. 2018 Jan 01; 42(1):13-26. PMID: 29320335.
      View in: PubMed
    9. Dow AW, Zhu X, Sewell D, Banas CA, Mishra V, Tu SP. Teamwork on the rocks: Rethinking interprofessional practice as networking. J Interprof Care. 2017 Nov; 31(6):677-678. PMID: 28792251.
      View in: PubMed
    10. Krist AH, Woolf SH, Hochheimer C, Sabo RT, Kashiri P, Jones RM, Lafata JE, Etz RS, Tu SP. Harnessing Information Technology to Inform Patients Facing Routine Decisions: Cancer Screening as a Test Case. Ann Fam Med. 2017 05; 15(3):217-224. PMID: 28483886.
      View in: PubMed
    11. Sin MK, Yip MP, Kimura A, Tu SP. Facilitators and Hindrances of Implementing Colorectal Cancer Screening Intervention Among Vietnamese Americans. Cancer Nurs. 2017 May/Jun; 40(3):E41-E47. PMID: 27105470.
      View in: PubMed
    12. Lazzara EH, Keebler JR, Day S, DiazGranados D, Pan M, King MA, Tu SP. Understanding Teamwork in the Provision of Cancer Care: Highlighting the Role of Trust. J Oncol Pract. 2016 11; 12(11):1084-1090. PMID: 27601505.
      View in: PubMed
    13. Bowles D, McIntosh G, Hemrajani R, Yen MS, Phillips A, Schwartz N, Tu SP, Dow AW. Nurse-physician collaboration in an academic medical centre: The influence of organisational and individual factors. J Interprof Care. 2016 Sep; 30(5):655-60. PMID: 27388560.
      View in: PubMed
    14. Sin MK, Taylor V, Tu SP. Issues in Lung Cancer Screening Among Asian American Immigrants. J Immigr Minor Health. 2016 06; 18(3):495-6. PMID: 26048357.
      View in: PubMed
    15. Tu SM, Bilen MA, Tannir NM. Personalised cancer care: promises and challenges of targeted therapy. J R Soc Med. 2016 Mar; 109(3):98-105. PMID: 26933155.
      View in: PubMed
    16. Eisenberg D, Seino L, Meischke H, Tu SP, Turner AM, Ike B, Painter I, Yip MP. Development of a Culturally-Adapted Graphic Novella about Emergency Communication: Collaborations with a Limited English Speaking Chinese Immigrant Community. J Health Care Poor Underserved. 2016; 27(3):1199-210. PMID: 27524762.
      View in: PubMed
    17. Cole AM, Tu SP, Fernandez ME, Calo WA, Hotz J, Wolver S. Reported Use of Electronic Health Records to Implement Evidence Based Approaches to Colorectal Cancer Screening in Community Health Centers. J Health Care Poor Underserved. 2015 Nov; 26(4):1235-45. PMID: 26548676.
      View in: PubMed
    18. Meischke H, Ike B, Painter I, Chavez D, Yip MP, Bradley SM, Tu SP. Delivering 9-1-1 CPR Instructions to Limited English Proficient Callers: A Simulation Experiment. J Immigr Minor Health. 2015 Aug; 17(4):1049-54. PMID: 24722975.
      View in: PubMed
    19. Yip MP, Chun A, Edelson J, Feng X, Tu SP. Contexts for Sustainable Implementation of a Colorectal Cancer Screening Program at a Community Health Center. Health Promot Pract. 2016 Jan; 17(1):48-56. PMID: 26202774.
      View in: PubMed
    20. Tu SM, Bilen MA, Lin SH. Radium-223: Optimizing Treatment and Research of Osteoblastic Bone Metastasis. Oncology (Williston Park). 2015 Jul; 29(7):490-2. PMID: 26178337.
      View in: PubMed
    21. Pagliaro LC, Tannir NM, Tu SM, Logothetis CJ. Management of Clinical Stage I Testicular Cancer: How Should We Define Success? J Clin Oncol. 2015 Jul 10; 33(20):2321-2. PMID: 26033805.
      View in: PubMed
    22. Wu W, Liu X, Chaftari P, Cruz Carreras MT, Gonzalez C, Viets-Upchurch J, Merriman K, Tu SM, Dalal S, Yeung SC. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review. PLoS One. 2015; 10(3):e0122047. PMID: 25822612; PMCID: PMC4379069.
    23. Bilen MA, Lin SH, Tang DG, Parikh K, Lee MH, Yeung SC, Tu SM. Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Rep Oncol Med. 2015; 2015:471861. PMID: 25861496; PMCID: PMC4377453.
    24. Tu SP, Young VM, Coombs LJ, Williams RS, Kegler MC, Kimura AT, Risendal BC, Friedman DB, Glenn BA, Pfeiffer DJ, Fernandez ME. Practice adaptive reserve and colorectal cancer screening best practices at community health center clinics in 7 states. Cancer. 2015 Apr 15; 121(8):1241-8. PMID: 25524651; PMCID: PMC4393345.
    25. Kimura A, Sin MK, Spigner C, Tran A, Tu SP. Barriers and facilitators to colorectal cancer screening in Vietnamese Americans: a qualitative analysis. J Cancer Educ. 2014 Dec; 29(4):728-34. PMID: 24756545; PMCID: PMC4334440.
    26. Bilen MA, Reyes A, Bhowmick D, Maa A, Bast R, Pisters LL, Lin SH, Logothetis CJ, Tu SM. Variant prostate carcinoma and elevated serum CA-125. Can J Urol. 2014 Oct; 21(5):7442-8. PMID: 25347368; PMCID: PMC4400850.
    27. Bilen MA, Johnson MM, Mathew P, Pagliaro LC, Araujo JC, Aparicio A, Corn PG, Tannir NM, Wong FC, Fisch MJ, Logothetis CJ, Tu SM. Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer. Cancer. 2015 Jan 01; 121(1):69-76. PMID: 25155428; PMCID: PMC4270821.
    28. Yip MP, Calhoun RE, Painter IS, Meischke HW, Tu SP. Emergency communications within the limited English proficient Chinese community. J Immigr Minor Health. 2014 Aug; 16(4):769-71. PMID: 24158381.
      View in: PubMed
    29. Wang JH, Liang W, Ma GX, Gehan E, Wang HE, Ji CS, Tu SP, Vernon SW, Mandelblatt JS. Promoting Chinese-speaking primary care physicians' communication with immigrant patients about colorectal cancer screening: a cluster randomized trial design. J Health Care Poor Underserved. 2014 Aug; 25(3):1079-100. PMID: 25130226.
      View in: PubMed
    30. Tu SP, Chun A, Yasui Y, Kuniyuki A, Yip MP, Taylor V, Bastani R. Adaptation of an evidence-based intervention to promote colorectal cancer screening: a quasi-experimental study. Implement Sci. 2014 Jul 02; 9:85. PMID: 24989083; PMCID: PMC4226971.
    31. Efstathiou E, Titus M, Wen S, Hoang A, Karlou M, Ashe R, Tu SM, Aparicio A, Troncoso P, Mohler J, Logothetis CJ. Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancer. Eur Urol. 2015 Jan; 67(1):53-60. PMID: 24882673; PMCID: PMC4247811.
    32. Painter I, Chavez DE, Ike BR, Yip MP, Tu SP, Bradley SM, Rea TD, Meischke H. Changes to DA-CPR instructions: can we reduce time to first compression and improve quality of bystander CPR? Resuscitation. 2014 Sep; 85(9):1169-73. PMID: 24864063.
      View in: PubMed
    33. Hamdi A, Mulanovich VE, Matin SF, Landon G, Sircar K, Tu SM, Nieto Y. Isolated renal mucormycosis in a transplantation recipient. J Clin Oncol. 2015 Apr 01; 33(10):e50-1. PMID: 24821884.
      View in: PubMed
    34. Tu SM, Bilen MA, Tannir NM. The scientific method: pillar and pitfall of cancer research. Cancer Med. 2014 Aug; 3(4):1035-7. PMID: 24711219; PMCID: PMC4303171.
    35. Bilen MA, Hariri H, Leon C, Guo CC, Kuban DA, Pisters LL, Tu SM. Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature. Clin Genitourin Cancer. 2014 Aug; 12(4):e147-50. PMID: 24674785; PMCID: PMC4104212.
    36. Meischke HW, Calhoun RE, Yip MP, Tu SP, Painter IS. The effect of language barriers on dispatching EMS response. Prehosp Emerg Care. 2013 Oct-Dec; 17(4):475-80. PMID: 23952940.
      View in: PubMed
    37. Som A, Xiao L, Zhu R, Guo CC, Xiao L, Rao P, Efstathiou E, Matin A, Tu SM. Clinically atypical seminomas with yolk sac tumor features. Can J Urol. 2013 Aug; 20(4):6860-7. PMID: 23930614.
      View in: PubMed
    38. Som A, Wen S, Tu SM. Stem cell origin of testicular seminoma. Clin Genitourin Cancer. 2013 Dec; 11(4):489-94. PMID: 23850550; PMCID: PMC3834099.
    39. Tu SM. Cancer: a "stem-cell" disease? Cancer Cell Int. 2013 May 06; 13(1):40. PMID: 23647946; PMCID: PMC3651409.
    40. Aparicio AM, Harzstark AL, Corn PG, Wen S, Araujo JC, Tu SM, Pagliaro LC, Kim J, Millikan RE, Ryan C, Tannir NM, Zurita AJ, Mathew P, Arap W, Troncoso P, Thall PF, Logothetis CJ. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res. 2013 Jul 01; 19(13):3621-30. PMID: 23649003; PMCID: PMC3699964.
    41. Sohng HY, Kuniyuki A, Edelson J, Weir RC, Song H, Tu SP. Capability for change at community health centers serving Asian Pacific Islanders: an exploratory study of a cancer screening evidence-based intervention. Asian Pac J Cancer Prev. 2013; 14(12):7451-7. PMID: 24460318.
      View in: PubMed
    42. Tu SP, Feng S, Storch R, Yip MP, Sohng H, Fu M, Chun A. Applying systems engineering to implement an evidence-based intervention at a community health center. J Health Care Poor Underserved. 2012 Nov; 23(4):1399-409. PMID: 23698657; PMCID: PMC3856720.
    43. Bilen MA, Kim J, Wang H, Tu SM. Cixutumumab-associated pancolitis in a patient with prostate cancer. Clin Genitourin Cancer. 2013 Jun; 11(2):207-10. PMID: 23083799; PMCID: PMC3579009.
    44. Som A, Tu SM, Liu J, Wang X, Qiao W, Logothetis C, Corn PG. Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials. Br J Cancer. 2012 Oct 23; 107(9):1547-53. PMID: 23033003; PMCID: PMC3493771.
    45. Tu SM, Som A, Tu B, Logothetis CJ, Lee MH, Yeung SC. Effect of Paget's disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis. Br J Cancer. 2012 Aug 07; 107(4):646-51. PMID: 22805323; PMCID: PMC3419961.
    46. Tu SM, Chen AH. Re: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases. Can J Urol. 2012 Jun; 19(3):6268. PMID: 22704311.
      View in: PubMed
    47. Ong BN, Yip MP, Feng S, Calhoun R, Meischke HW, Tu SP. Barriers and facilitators to using 9-1-1 and emergency medical services in a limited English proficiency Chinese community. J Immigr Minor Health. 2012 Apr; 14(2):307-13. PMID: 21286812.
      View in: PubMed
    48. Tu SM, Lin SH. Prostate cancer stem cells. Clin Genitourin Cancer. 2012 Jun; 10(2):69-76. PMID: 22421313; PMCID: PMC4141775.
    49. Meischke H, Taylor V, Calhoun R, Liu Q, Sos C, Tu SP, Yip MP, Eisenberg D. Preparedness for cardiac emergencies among Cambodians with limited English proficiency. J Community Health. 2012 Feb; 37(1):176-80. PMID: 21748487.
      View in: PubMed
    50. Yennurajalingam S, Atkinson B, Masterson J, Hui D, Urbauer D, Tu SM, Bruera E. The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. J Palliat Med. 2012 Jan; 15(1):20-4. PMID: 22141432.
      View in: PubMed
    51. Staquicini FI, Cardó-Vila M, Kolonin MG, Trepel M, Edwards JK, Nunes DN, Sergeeva A, Efstathiou E, Sun J, Almeida NF, Tu SM, Botz GH, Wallace MJ, O'Connell DJ, Krajewski S, Gershenwald JE, Molldrem JJ, Flamm AL, Koivunen E, Pentz RD, Dias-Neto E, Setubal JC, Cahill DJ, Troncoso P, Do KA, Logothetis CJ, Sidman RL, Pasqualini R, Arap W. Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proc Natl Acad Sci U S A. 2011 Nov 15; 108(46):18637-42. PMID: 22049339; PMCID: PMC3219136.
    52. Manoukian GE, Tannir NM, Jonasch E, Qiao W, Haygood TM, Tu SM. Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma. Clin Genitourin Cancer. 2011 Dec; 9(2):81-8. PMID: 21958521; PMCID: PMC3641665.
    53. Atkinson BJ, Tu SM. Radiopharmaceuticals: present and future. J Support Oncol. 2011 Nov-Dec; 9(6):206-7. PMID: 22005215.
      View in: PubMed
    54. Emmons KM, Weiner B, Fernandez ME, Tu SP. Systems antecedents for dissemination and implementation: a review and analysis of measures. Health Educ Behav. 2012 Feb; 39(1):87-105. PMID: 21724933.
      View in: PubMed
    55. Bilen MA, General R, Tu SM. Prolonged remission of fulminant castrate-resistant prostate cancer: a case report. Clin Genitourin Cancer. 2011 Dec; 9(2):133-6. PMID: 21729684; PMCID: PMC3205279.
    56. Yip MP, Ong BN, Meischke HW, Feng SX, Calhoun R, Painter I, Tu SP. The role of self-efficacy in communication and emergency response in Chinese limited english proficiency (LEP) populations. Health Promot Pract. 2013 May; 14(3):400-7. PMID: 21460258.
      View in: PubMed
    57. He XX, Tu SM, Lee MH, Yeung SC. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol. 2011 Dec; 22(12):2640-5. PMID: 21415239; PMCID: PMC3221513.
    58. Yip MP, Ong B, Tu SP, Chavez D, Ike B, Painter I, Lam I, Bradley SM, Coronado GD, Meischke HW. Diffusion of cardiopulmonary resuscitation training to chinese immigrants with limited english proficiency. Emerg Med Int. 2011; 2011:685249. PMID: 22046544.
      View in: PubMed
    59. Mathew P, Tannir N, Tu SM, Wen S, Guo CC, Marcott V, Bekele BN, Pagliaro L. Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib. Cancer Chemother Pharmacol. 2011 Oct; 68(4):889-96. PMID: 21290244.
      View in: PubMed
    60. Ton TG, Steinman L, Yip MP, Ly KA, Sin MK, Fitzpatrick AL, Tu SP. Knowledge of cardiovascular health among Chinese, Korean and Vietnamese immigrants to the US. J Immigr Minor Health. 2011 Feb; 13(1):127-39. PMID: 20306224.
      View in: PubMed
    61. Fitzpatrick AL, Steinman LE, Tu SP, Ly KA, Ton TG, Yip MP, Sin MK. Using photovoice to understand cardiovascular health awareness in Asian elders. Health Promot Pract. 2012 Jan; 13(1):48-54. PMID: 21057047.
      View in: PubMed
    62. Rodney AJ, Tannir NM, Siefker-Radtke AO, Liu P, Walsh GL, Millikan RE, Swisher SG, Tu SM, Pagliaro LC. Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience. Urol Oncol. 2012 Nov-Dec; 30(6):879-85. PMID: 20933444; PMCID: PMC3956468.
    63. Som A, Zhu R, Guo CC, Efstathiou E, Xiao L, Pisters LL, Matin A, Tu SM. Recurrent seminomas: clinical features and biologic implications. Urol Oncol. 2012 Jul-Aug; 30(4):494-501. PMID: 20822932; PMCID: PMC3856193.
    64. Tu SM, Lin SH, Podoloff DA, Logothetis CJ. Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer. Clin Adv Hematol Oncol. 2010 May; 8(5):341-51. PMID: 20551894; PMCID: PMC4993042.
    65. Contreras AL, Punar M, Tamboli P, Tu SM, Pisters L, Moran C, Czerniak BA, Guo CC. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol. 2010 Jun; 41(6):832-7. PMID: 20153508; PMCID: PMC4163004.
    66. Mathew P, Tannir N, Tu SM, Carter CM, Bekele NB, Pagliaro L. A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy. Cancer Chemother Pharmacol. 2010 Mar; 65(4):811-5. PMID: 20052472; PMCID: PMC4436674.
    67. Tu SM. Origin of cancers. Clinical perspectives and implications of a stem-cell theory of cancer. Cancer Treat Res. 2010; 154:v-239. PMID: 20645140.
      View in: PubMed
    68. Tu SP, Yip MP, Li L, Chun A, Taylor V, Yasui Y. Continuity of care and colorectal cancer screening by Vietnamese American patients. Asian Pac J Cancer Prev. 2010; 11(4):1125-31. PMID: 21133636; PMCID: PMC3856709.
    69. Fitzpatrick AL, Steinman LE, Tu SP, Ly KA, Ton TG, Yip MP, Sin MK. Communicating with pictures: perceptions of cardiovascular health among Asian immigrants. Am J Public Health. 2009 Dec; 99(12):2147-9. PMID: 19903905; PMCID: PMC2775757.
    70. Taplin ME, Regan MM, Ko YJ, Bubley GJ, Duggan SE, Werner L, Beer TM, Ryan CW, Mathew P, Tu SM, Denmeade SR, Oh WK, Sartor O, Mantzoros CS, Rittmaster R, Kantoff PW, Balk SP. Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. Clin Cancer Res. 2009 Nov 15; 15(22):7099-105. PMID: 19887483; PMCID: PMC3644858.
    71. Yip MP, Ong B, Painter I, Meischke H, Calhoun B, Tu SP. Information-seeking behaviors and response to the H1N1 outbreak in Chinese limited-English proficient individuals living in King County, Washington. Am J Disaster Med. 2009 Nov-Dec; 4(6):353-60. PMID: 20104728.
      View in: PubMed
    72. Guo CC, Punar M, Contreras AL, Tu SM, Pisters L, Tamboli P, Czerniak B. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol. 2009 Aug; 33(8):1173-8. PMID: 19561445; PMCID: PMC3812063.
    73. Jonasch E, Wood CG, Matin SF, Tu SM, Pagliaro LC, Corn PG, Aparicio A, Tamboli P, Millikan RE, Wang X, Araujo JC, Arap W, Tannir N. Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol. 2009 Sep 01; 27(25):4076-81. PMID: 19636008; PMCID: PMC4371138.
    74. Tu SM, Lopez A, Leibovici D, Bilen MA, Evliyaoglu F, Aparicio A, Guo CC, Kuban DA, Johnson MM, Pisters LL. Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy. Cancer. 2009 Jul 01; 115(13):2872-80. PMID: 19402048.
      View in: PubMed
    75. Taylor VM, Hislop TG, Tu SP, Teh C, Acorda E, Yip MP, Woodall E, Yasui Y. Evaluation of a hepatitis B lay health worker intervention for Chinese Americans and Canadians. J Community Health. 2009 Jun; 34(3):165-72. PMID: 19127416; PMCID: PMC2735565.
    76. Tu SM, Mathew P, Wong FC, Jones D, Johnson MM, Logothetis CJ. Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer. J Clin Oncol. 2009 Jul 10; 27(20):3319-24. PMID: 19414670; PMCID: PMC4371137.
    77. Williams BJ, Fox BD, Sciubba DM, Suki D, Tu SM, Kuban D, Gokaslan ZL, Rhines LD, Rao G. Surgical management of prostate cancer metastatic to the spine. J Neurosurg Spine. 2009 May; 10(5):414-22. PMID: 19442002.
      View in: PubMed
    78. Svatek RS, Spiess PE, Sundi D, Tu SM, Tannir NM, Brown GA, Kamat AM, Wood CG, Pisters LL. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer. 2009 Mar 15; 115(6):1310-7. PMID: 19156903.
      View in: PubMed
    79. Gnjatic S, Altorki NK, Tang DN, Tu SM, Kundra V, Ritter G, Old LJ, Logothetis CJ, Sharma P. NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells. Clin Cancer Res. 2009 Mar 15; 15(6):2130-9. PMID: 19276258.
      View in: PubMed
    80. Hislop TG, Bajdik CD, Teh C, Lam W, Tu SP, Yasui Y, Bastani R, Taylor VM. Hepatitis B testing and vaccination in immigrants attending English as a second language classes in British Columbia, Canada. Asian Pac J Cancer Prev. 2009; 10(6):997-1002. PMID: 20192572; PMCID: PMC2862471.
    81. Woodall ED, Taylor VM, Teh C, Li L, Acorda E, Tu SP, Yasui Y, Hislop TG. Sources of health information among Chinese immigrants to the Pacific Northwest. J Cancer Educ. 2009; 24(4):334-40. PMID: 19838895; PMCID: PMC2836713.
    82. Tu SP, Yip MP, Chun A, Choe J, Bastani R, Taylor V. Development of intervention materials for individuals with limited English proficiency: lessons learned from "Colorectal Cancer Screening in Chinese Americans". Med Care. 2008 Sep; 46(9 Suppl 1):S51-61. PMID: 18725834; PMCID: PMC3860055.
    83. Bilen MA, Waguespack SG, Tannir NM, Pravinkumar SE, Tamboli P, Tu SM. Multisystem crisis in a patient with presumptive renal cell carcinoma. Clin Genitourin Cancer. 2008 Sep; 6(2):128-30. PMID: 18824438.
      View in: PubMed
    84. Taylor VM, Coronado G, Acorda E, Teh C, Tu SP, Yasui Y, Bastani R, Hislop TG. Development of an ESL curriculum to educate Chinese immigrants about hepatitis B. J Community Health. 2008 Aug; 33(4):217-24. PMID: 18373185; PMCID: PMC2691859.
    85. Lin SH, Lee YC, Choueiri MB, Wen S, Mathew P, Ye X, Do KA, Navone NM, Kim J, Tu SM, Yu-Lee LY, Logothetis CJ. Soluble ErbB3 levels in bone marrow and plasma of men with prostate cancer. Clin Cancer Res. 2008 Jun 15; 14(12):3729-36. PMID: 18559590; PMCID: PMC2562877.
    86. Lin SH, Cheng CJ, Lee YC, Ye X, Tsai WW, Kim J, Pasqualini R, Arap W, Navone NM, Tu SM, Hu M, Yu-Lee LY, Logothetis CJ. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008 Sep 04; 27(39):5195-203. PMID: 18490922; PMCID: PMC2562662.
    87. Hislop TG, Teh C, Low A, Yasui Y, Tu SP, Li L, Taylor VM. Knowledge and behaviour regarding heart disease prevention in Chinese Canadian immigrants. Can J Public Health. 2008 May-Jun; 99(3):232-5. PMID: 18615948.
      View in: PubMed
    88. Jonasch E, Wood C, Tamboli P, Pagliaro LC, Tu SM, Kim J, Srivastava P, Perez C, Isakov L, Tannir N. Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings. Br J Cancer. 2008 Apr 22; 98(8):1336-41. PMID: 18362942; PMCID: PMC2361701.
    89. Tu SM, Lin SH. Current trials using bone-targeting agents in prostate cancer. Cancer J. 2008 Jan-Feb; 14(1):35-9. PMID: 18303481.
      View in: PubMed
    90. Spiess PE, Tannir NM, Tu SM, Brown GA, Liu P, Kamat AM, Wood CG, Evans JG, Pisters LL. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression? Cancer. 2007 Dec 15; 110(12):2700-8. PMID: 17948916.
      View in: PubMed
    91. Spiess PE, Tannir NM, Brown GA, Liu P, Tu SM, Evans JG, Pisters LL. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection. Urology. 2007 Dec; 70(6):1173-8. PMID: 18158041.
      View in: PubMed
    92. Coronado GD, Taylor VM, Tu SP, Yasui Y, Acorda E, Woodall E, Yip MP, Li L, Hislop TG. Correlates of hepatitis B testing among Chinese Americans. J Community Health. 2007 Dec; 32(6):379-90. PMID: 17940869.
      View in: PubMed
    93. Taylor VM, Yasui Y, Tu SP, Neuhouser ML, Li L, Woodall E, Acorda E, Cripe SM, Hislop TG. Heart disease prevention among Chinese immigrants. J Community Health. 2007 Oct; 32(5):299-310. PMID: 17922202.
      View in: PubMed
    94. Mathew P, Thall PF, Bucana CD, Oh WK, Morris MJ, Jones DM, Johnson MM, Wen S, Pagliaro LC, Tannir NM, Tu SM, Meluch AA, Smith L, Cohen L, Kim SJ, Troncoso P, Fidler IJ, Logothetis CJ. Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases. Clin Cancer Res. 2007 Oct 01; 13(19):5816-24. PMID: 17908974.
      View in: PubMed
    95. Chan NL, Thompson B, Taylor VM, Yasui Y, Harris JR, Tu SP, Acorda E, Jackson JC. Smoking prevalence, knowledge, and attitudes among a population of Vietnamese American men. Nicotine Tob Res. 2007 Sep; 9 Suppl 3:S475-84. PMID: 17978976.
      View in: PubMed
    96. Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am. 2007 Aug; 89(8):1794-801. PMID: 17671020.
      View in: PubMed
    97. Cheng CJ, Ye XC, Vakar-Lopez F, Kim J, Tu SM, Chen DT, Navone NM, Yu-Lee LY, Lin SH, Hu MC. Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells. Mol Cancer Res. 2007 Jul; 5(7):675-84. PMID: 17634423; PMCID: PMC2000833.
    98. Spigner C, Yip MP, Huang B, Tu SP. Chinese and Vietnamese adult male smokers' perspectives regarding facilitators of tobacco cessation behavior. Asian Pac J Cancer Prev. 2007 Jul-Sep; 8(3):429-35. PMID: 18159982.
      View in: PubMed
    99. Ye XC, Choueiri M, Tu SM, Lin SH. Biology and clinical management of prostate cancer bone metastasis. Front Biosci. 2007 May 01; 12:3273-86. PMID: 17485298.
      View in: PubMed
    100. Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, Tu SM, Tannir NM, Pisters LL. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol. 2007 Apr; 177(4):1330-4; discussion 1334. PMID: 17382725.
      View in: PubMed
    101. Kopetz S, Jimenez C, Tu SM, Sharma P. Pulmonary arteriovenous fistula in a patient with renal cell carcinoma. Eur Respir J. 2007 Apr; 29(4):813-5. PMID: 17400880.
      View in: PubMed
    102. Chan NL, Yasui Y, Thompson B, Taylor VM, Tu SP, Do H, Harris JR, Jackson JC. Secondhand smoke in the home and Pap testing among Vietnamese American women. Asian Pac J Cancer Prev. 2007 Apr-Jun; 8(2):178-82. PMID: 17696727.
      View in: PubMed
    103. Hislop TG, Teh C, Low A, Li L, Tu SP, Yasui Y, Taylor VM. Hepatitis B knowledge, testing and vaccination levels in Chinese immigrants to British Columbia, Canada. Can J Public Health. 2007 Mar-Apr; 98(2):125-9. PMID: 17441536.
      View in: PubMed
    104. Leibovici D, Spiess PE, Agarwal PK, Tu SM, Pettaway CA, Hitzhusen K, Millikan RE, Pisters LL. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer. 2007 Jan 15; 109(2):198-204. PMID: 17171704.
      View in: PubMed
    105. Tuziak T, Spiess PE, Abrahams NA, Wrona A, Tu SM, Czerniak B. Multilocular cystadenoma and cystadenocarcinoma of the prostate. Urol Oncol. 2007 Jan-Feb; 25(1):19-25. PMID: 17208134.
      View in: PubMed
    106. Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection. J Urol. 2007 Jan; 177(1):131-8. PMID: 17162023.
      View in: PubMed
    107. Hislop TG, Teh C, Low A, Tu SP, Yasui Y, Coronado GD, Li LL, Taylor VM. Predisposing, reinforcing and enabling factors associated with hepatitis B testing in Chinese Canadians in British Columbia. Asian Pac J Cancer Prev. 2007 Jan-Mar; 8(1):39-44. PMID: 17477769.
      View in: PubMed
    108. Choueiri MB, Tu SM, Yu-Lee LY, Lin SH. The central role of osteoblasts in the metastasis of prostate cancer. Cancer Metastasis Rev. 2006 Dec; 25(4):601-9. PMID: 17160554.
      View in: PubMed
    109. Pagliaro LC, Perez CA, Tu SM, Daliani DD. Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma. Urol Oncol. 2006 Nov-Dec; 24(6):487-91. PMID: 17138128.
      View in: PubMed
    110. Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters? Cancer. 2006 Oct 01; 107(7):1503-10. PMID: 16944534.
      View in: PubMed
    111. Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Cancer. 2006 Oct 01; 107(7):1483-90. PMID: 16944541.
      View in: PubMed
    112. Yip MP, Tu SP, Chun A, Yasui Y, Taylor VM. Participation in colorectal cancer screening among Chinese Americans. Asian Pac J Cancer Prev. 2006 Oct-Dec; 7(4):645-50. PMID: 17250445.
      View in: PubMed
    113. Tu SP, Taylor V, Yasui Y, Chun A, Yip MP, Acorda E, Li L, Bastani R. Promoting culturally appropriate colorectal cancer screening through a health educator: a randomized controlled trial. Cancer. 2006 Sep 01; 107(5):959-66. PMID: 16865681.
      View in: PubMed
    114. Tannir N, Jonasch E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma. Cancer. 2006 Aug 01; 107(3):497-505. PMID: 16795067.
      View in: PubMed
    115. Hu KK, Woodall ED, Do HH, Tu SP, Thompson B, Acorda E, Li L, Taylor VM. Tobacco knowledge and beliefs in Chinese American men. Asian Pac J Cancer Prev. 2006 Jul-Sep; 7(3):434-8. PMID: 17059339.
      View in: PubMed
    116. Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Improving identification of cognitive impairment in primary care. Int J Geriatr Psychiatry. 2006 Apr; 21(4):349-55. PMID: 16534774.
      View in: PubMed
    117. Chen H, Tu SP, Teh CZ, Yip MP, Choe JH, Hislop TG, Taylor VM, Thompson B. Lay beliefs about hepatitis among North American Chinese: implications for hepatitis prevention. J Community Health. 2006 Apr; 31(2):94-112. PMID: 16737171.
      View in: PubMed
    118. Taylor VM, Tu SP, Woodall E, Acorda E, Chen H, Choe J, Li L, Yasui Y, Hislop TG. Hepatitis B knowledge and practices among Chinese immigrants to the United States. Asian Pac J Cancer Prev. 2006 Apr-Jun; 7(2):313-7. PMID: 16839229.
      View in: PubMed
    119. Choe JH, Tu SP, Lim JM, Burke NJ, Acorda E, Taylor VM. "Heat in their intestine": colorectal cancer prevention beliefs among older Chinese Americans. Ethn Dis. 2006; 16(1):248-54. PMID: 16599379.
      View in: PubMed
    120. Tu SP, Reisch LM, Taplin SH, Kreuter W, Elmore JG. Breast self-examination: self-reported frequency, quality, and associated outcomes. J Cancer Educ. 2006; 21(3):175-81. PMID: 17371185.
      View in: PubMed
    121. Tu SP, Chen H, Chen A, Lim J, May S, Drescher C. Clinical trials: understanding and perceptions of female Chinese-American cancer patients. Cancer. 2005 Dec 15; 104(12 Suppl):2999-3005. PMID: 16247796; PMCID: PMC1810650.
    122. Seng P, Acorda E, Carey Jackson J, Marchand A, Thai H, Tu SP, Taylor V. AANCART best practices: cancer awareness activities for Seattle's Combodian community. Cancer. 2005 Dec 15; 104(12 Suppl):2916-9. PMID: 16276540; PMCID: PMC1811046.
    123. Tu SM, Kim J, Pagliaro LC, Vakar-Lopez F, Wong FC, Wen S, General R, Podoloff DA, Lin SH, Logothetis CJ. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy. J Clin Oncol. 2005 Nov 01; 23(31):7904-10. PMID: 16258090.
      View in: PubMed
    124. Spigner C, Shigaki A, Tu SP. Perceptions of Asian American men about tobacco cigarette consumption: a social learning theory framework. J Immigr Health. 2005 Oct; 7(4):293-303. PMID: 19813295.
      View in: PubMed
    125. Tu SP, Jackson SL, Yasui Y, Deschamps M, Hislop TG, Taylor VM. Cancer preventive screening: a cross-border comparison of United States and Canadian Chinese women. Prev Med. 2005 Jul; 41(1):36-46. PMID: 15916991.
      View in: PubMed
    126. D'Orsi C, Tu SP, Nakano C, Carney PA, Abraham LA, Taplin SH, Hendrick RE, Cutter GR, Berns E, Barlow WE, Elmore JG. Current realities of delivering mammography services in the community: do challenges with staffing and scheduling exist? Radiology. 2005 May; 235(2):391-5. PMID: 15798153; PMCID: PMC3143037.
    127. Papandreou CN, Daliani DD, Nix D, Yang H, Madden T, Wang X, Pien CS, Millikan RE, Tu SM, Pagliaro L, Kim J, Adams J, Elliott P, Esseltine D, Petrusich A, Dieringer P, Perez C, Logothetis CJ. Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer. J Clin Oncol. 2004 Jun 01; 22(11):2108-21. PMID: 15169797.
      View in: PubMed
    128. Vakar-Lopez F, Cheng CJ, Kim J, Shi GG, Troncoso P, Tu SM, Yu-Lee LY, Lin SH. Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow. J Pathol. 2004 Jun; 203(2):688-95. PMID: 15141384.
      View in: PubMed
    129. Tu SM, Lin SH. Clinical aspects of bone metastases in prostate cancer. Cancer Treat Res. 2004; 118:23-46. PMID: 15043187.
      View in: PubMed
    130. Hislop TG, Inrig KM, Bajdik CD, Deschamps M, Tu SP, Taylor VM. Health care services and Pap testing behavior for Chinese women in British Columbia. J Immigr Health. 2003 Oct; 5(4):143-52. PMID: 14574065.
      View in: PubMed
    131. Taylor V, Lessler D, Mertens K, Tu SP, Hart A, Chan N, Shu J, Thompson B. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc. 2003 Sep; 95(9):806-12. PMID: 14527047; PMCID: PMC2594456.
    132. Tu SM, Millikan RE, Pagliaro LC, Daliani D, Papandreou CN, Kim J, Chen DT, Williams DL, Logothetis CJ. Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP). Urol Oncol. 2003 Sep-Oct; 21(5):342-8. PMID: 14670540.
      View in: PubMed
    133. Tu SM, Lin SH, Logothetis C. Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2003 Aug 06; 95(15):1174-5; author reply 1175. PMID: 12902452.
      View in: PubMed
    134. Esmaeli B, Hidaji L, Adinin RB, Faustina M, Coats C, Arbuckle R, Rivera E, Valero V, Tu SM, Ahmadi MA. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy. Cancer. 2003 Aug 01; 98(3):504-7. PMID: 12879466.
      View in: PubMed
    135. Jackson SL, Hislop TG, Teh C, Yasui Y, Tu SP, Kuniyuki A, Jackson JC, Taylor VM. Screening mammography among Chinese Canadian women. Can J Public Health. 2003 Jul-Aug; 94(4):275-80. PMID: 12873086.
      View in: PubMed
    136. Pagliaro LC, Delpassand ES, Williams D, Millikan RE, Tu SM, Logothetis CJ. A Phase I/II study of strontium-89 combined with gemcitabine in the treatment of patients with androgen independent prostate carcinoma and bone metastases. Cancer. 2003 Jun 15; 97(12):2988-94. PMID: 12784333.
      View in: PubMed
    137. Tu SP, Yasui Y, Kuniyuki AA, Schwartz SM, Jackson JC, Hislop TG, Taylor V. Mammography screening among Chinese-American women. Cancer. 2003 Mar 01; 97(5):1293-302. PMID: 12599238.
      View in: PubMed
    138. Ralston JD, Taylor VM, Yasui Y, Kuniyuki A, Jackson JC, Tu SP. Knowledge of cervical cancer risk factors among Chinese immigrants in Seattle. J Community Health. 2003 Feb; 28(1):41-57. PMID: 12570172; PMCID: PMC1618780.
    139. Logothetis C, Tu SM, Navone N. Targeting prostate cancer bone metastases. Cancer. 2003 Feb 01; 97(3 Suppl):785-8. PMID: 12548576.
      View in: PubMed
    140. Daliani DD, Assikis V, Tu SM, Papandreou CN, Pagliaro LC, Holtkamp T, Wang X, Thall PF, Logothetis CJ. Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma. Cancer. 2003 Feb 01; 97(3):561-7. PMID: 12548597.
      View in: PubMed
    141. Kim J, Millikan RE, Smith TL, Tu SM, Pagliaro LC, Logothetis CJ. Treating refractory advanced or metastatic urothelial carcinoma with interleukin-2: a phase II study. Urol Oncol. 2003 Jan-Feb; 21(1):21-6. PMID: 12684123.
      View in: PubMed
    142. Tu SP, Jackson JC, Teh C, Lai A, Do H, Hsu L, Chan I, Tseng B, Hislop G, Taylor V. Translation challenges of cross-cultural research and program development. Asian Am Pac Isl J Health. 2003 Winter-Spring; 10(1):58-66. PMID: 15352776.
      View in: PubMed
    143. Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol. 2002 Aug; 3(8):508-13. PMID: 12147437.
      View in: PubMed
    144. Papandreou CN, Daliani DD, Thall PF, Tu SM, Wang X, Reyes A, Troncoso P, Logothetis CJ. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol. 2002 Jul 15; 20(14):3072-80. PMID: 12118020.
      View in: PubMed
    145. Pagliaro LC, Millikan RE, Tu SM, Williams D, Daliani D, Papandreou CN, Logothetis CJ. Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinoma. J Clin Oncol. 2002 Jul 01; 20(13):2965-70. PMID: 12089226.
      View in: PubMed
    146. Jackson JC, Do H, Chitnarong K, Tu SP, Marchand A, Hislop G, Taylor V. Development of cervical cancer control interventions for Chinese immigrants. J Immigr Health. 2002 Jul; 4(3):147-57. PMID: 16228758; PMCID: PMC1592327.
    147. Fizazi K, Prow DM, Do KA, Wang X, Finn L, Kim J, Daliani D, Papandreou CN, Tu SM, Millikan RE, Pagliaro LC, Logothetis CJ, Amato RJ. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. Br J Cancer. 2002 May 20; 86(10):1555-60. PMID: 12085204; PMCID: PMC2746595.
    148. Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer. 2002 May 15; 94(10):2610-7. PMID: 12173328.
      View in: PubMed
    149. Taylor VM, Hislop TG, Jackson JC, Tu SP, Yasui Y, Schwartz SM, Teh C, Kuniyuki A, Acorda E, Marchand A, Thompson B. A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J Natl Cancer Inst. 2002 May 01; 94(9):670-7. PMID: 11983755; PMCID: PMC1592333.
    150. Siefker-Radtke AO, Millikan RE, Tu SM, Moore DF, Smith TL, Williams D, Logothetis CJ. Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer. J Clin Oncol. 2002 Mar 01; 20(5):1361-7. PMID: 11870180.
      View in: PubMed
    151. Satia-Abouta J, Patterson RE, Kristal AR, Teh C, Tu SP. Psychosocial predictors of diet and acculturation in Chinese American and Chinese Canadian women. Ethn Health. 2002 Feb; 7(1):21-39. PMID: 12119064.
      View in: PubMed
    152. Taylor VM, Jackson JC, Yasui Y, Kuniyuki A, Acorda E, Marchand A, Schwartz SM, Tu SP, Thompson B. Evaluation of an outreach intervention to promote cervical cancer screening among Cambodian American women. Cancer Detect Prev. 2002; 26(4):320-7. PMID: 12430637; PMCID: PMC1592335.
    153. Tu SP, Yasui Y, Kuniyuki A, Schwartz SM, Jackson JC, Taylor VM. Breast cancer screening: stages of adoption among Cambodian American women. Cancer Detect Prev. 2002; 26(1):33-41. PMID: 12088201; PMCID: PMC1592336.
    154. Taylor VM, Jackson JC, Tu SP, Yasui Y, Schwartz SM, Kuniyuki A, Acorda E, Lin K, Hislop G. Cervical cancer screening among Chinese Americans. Cancer Detect Prev. 2002; 26(2):139-45. PMID: 12102148; PMCID: PMC1592328.
    155. Thompson MJ, Taylor VM, Jackson JC, Yasui Y, Kuniyuki A, Tu SP, Hislop TG. Hepatitis B knowledge and practices among Chinese American women in Seattle, Washington. J Cancer Educ. 2002; 17(4):222-6. PMID: 12556060.
      View in: PubMed
    156. Sexton WJ, Lance RE, Reyes AO, Pisters PW, Tu SM, Pisters LL. Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience. J Urol. 2001 Aug; 166(2):521-5. PMID: 11458058.
      View in: PubMed
    157. Park DS, Vassilopoulou Sellin R, Tu S. Estramustine-related hypocalcemia in patients with prostate carcinoma and osteoblastic metastases. Urology. 2001 Jul; 58(1):105. PMID: 11445494.
      View in: PubMed
    158. Tu SM, Millikan RE, Mengistu B, Delpassand ES, Amato RJ, Pagliaro LC, Daliani D, Papandreou CN, Smith TL, Kim J, Podoloff DA, Logothetis CJ. Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet. 2001 Feb 03; 357(9253):336-41. PMID: 11210994.
      View in: PubMed
    159. Pagliaro L, Daliani D, Amato R, Tu SM, Jones D, Smith T, Logothetis C, Millikan R. A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma. Cancer. 2000 Aug 01; 89(3):615-8. PMID: 10931461.
      View in: PubMed
    160. Tu SP, Walsh M, Tseng B, Thompson B. Tobacco Use by Chinese American Men: An Exploratory Study of the Factors Associated with Cigarette Use and Smoking Cessation. Asian Am Pac Isl J Health. 2000; 8(1):46-57. PMID: 11567512.
      View in: PubMed
    161. Taylor VM, Jackson JC, Tu SP. Cancer Control Research among Cambodian Americans in Washington. Asian Am Pac Isl J Health. 2000; 8(1):32-38. PMID: 11567509.
      View in: PubMed
    162. Beham AW, Sarkiss M, Brisbay S, Tu SM, von Eschenbach AC, McDonnell TJ. Molecular correlates of bcl-2-enhanced growth following androgen-ablation in prostate carcinoma cells in vivo. Int J Mol Med. 1998 Jun; 1(6):953-9. PMID: 9852630.
      View in: PubMed
    163. Tu SM, Pagliaro LC, Banks ME, Amato RJ, Millikan RE, Bugazia NA, Madden T, Newman RA, Logothetis CJ. Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer. Clin Cancer Res. 1998 May; 4(5):1193-201. PMID: 9607577.
      View in: PubMed
    164. Westney OL, Pisters LL, Pettaway CA, Tu SM, Pollack A, Dinney CP. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 1998 Mar; 159(3):792-5. PMID: 9474150.
      View in: PubMed
    165. Taylor VM, Jackson JC, Schwartz SM, Yasui Y, Tu SP, Thompson B. Cervical Cancer Control in a Cambodian American Population. Asian Am Pac Isl J Health. 1998; 6(2):368-377. PMID: 11567463.
      View in: PubMed
    166. Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2493-500. PMID: 9815652.
      View in: PubMed
    167. Ellerhorst JA, Sella A, Amato RJ, Tu SM, Millikan RE, Finn LD, Banks M, Logothetis CJ. Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma. Cancer. 1997 Dec 01; 80(11):2128-32. PMID: 9392335.
      View in: PubMed
    168. Ellerhorst JA, Tu SM, Amato RJ, Finn L, Millikan RE, Pagliaro LC, Jackson A, Logothetis CJ. Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer. Clin Cancer Res. 1997 Dec; 3(12 Pt 1):2371-6. PMID: 9815636.
      View in: PubMed
    169. Westin P, Lo P, Marin M, Fernandez A, Sarkiss M, Tu S, Brisbay S, Voneschenbach A, McDonnell T. bcl-2 expression confers androgen independence in androgen sensitive prostatic carcinoma. Int J Oncol. 1997 Jan; 10(1):113-8. PMID: 21533353.
      View in: PubMed
    170. Tu SM, Delpassand ES, Jones D, Amato RJ, Ellerhorst J, Logothetis CJ. Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer. Urol Oncol. 1996 Nov-Dec; 2(6):191-7. PMID: 21224168.
      View in: PubMed
    171. Taylor VM, Jackson JC, Schwartz SM, Tu SP, Thompson B. Cervical Cancer among Asian American Women: A Neglected Publica Health Problem? Asian Am Pac Isl J Health. 1996; 4(4):327-342. PMID: 11567375.
      View in: PubMed
    172. Tu SM, Hossan E, Amato R, Kilbourn R, Logothetis CJ. Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies. J Urol. 1995 Nov; 154(5):1719-22. PMID: 7563331.
      View in: PubMed
    173. Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ. Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial. J Clin Oncol. 1995 Sep; 13(9):2272-7. PMID: 7666085.
      View in: PubMed
    174. Tu SM, McConnell K, Marin MC, Campbell ML, Fernandez A, von Eschenbach AC, McDonnell TJ. Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells. Cancer Lett. 1995 Jul 13; 93(2):147-55. PMID: 7621422.
      View in: PubMed
    175. McDonnell TJ, Marin MC, Hsu B, Brisbay SM, McConnell K, Tu SM, Campbell ML, Rodriguez-Villanueva J. The bcl-2 oncogene: apoptosis and neoplasia. Radiat Res. 1993 Dec; 136(3):307-12. PMID: 8278571.
      View in: PubMed
    176. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992 Dec 15; 52(24):6940-4. PMID: 1458483.
      View in: PubMed
    177. Hou L, Shi D, Tu SM, Zhang HZ, Hung MC, Ling D. Oral cancer progression and c-erbB-2/neu proto-oncogene expression. Cancer Lett. 1992 Aug 31; 65(3):215-20. PMID: 1355405.
      View in: PubMed
    178. Deckmyn H, Tu SM, Majerus PW. Guanine nucleotides stimulate soluble phosphoinositide-specific phospholipase C in the absence of membranes. J Biol Chem. 1986 Dec 15; 261(35):16553-8. PMID: 3023354.
      View in: PubMed
    179. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer. PLoS One. 10.
    180. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors. Annals of Oncology. 26:2125-2132.
    181. Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation. Clinical Genitourinary Cancer.
    182. Expression of bcl-2 and its correlation with the development of androgen independent. Cancer Bulletin. 45:448-452.
    183. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi. Annals of Oncology. 26:2507-2508.
    184. Radium-223. ONCOLOGY (United States). 29.
    185. Safety of Same-day Pegfilgrastim Administration in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel With or Without Carboplatin. Clinical Genitourinary Cancer.
    186. Intratumoral heterogeneity. Cancer.
    187. Phase I-II study of Gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 12:365-370.
    188. Postacute Care in Cancer Rehabilitation. Physical Medicine and Rehabilitation Clinics of North America. 28:19-34.
    189. Corrigendum. Cancer Letters. 99:247.
    190. Stem cells in carcinogenesis of the prostate. 73-79.
    191. Editorial comment. Canadian Journal of Urology. 19:6268.
    192. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 7:86280-86289.
    193. Clinically atypical seminomas with yolk sac tumor features. Canadian Journal of Urology. 20:6860-6867.
    194. A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies. Urologic Oncology: Seminars and Original Investigations. 1:156-160.
    195. Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody. Journal for ImmunoTherapy of Cancer. 4.
    TU's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description